Role of FXR Agonist in Cholestasis Following Live Donor Liver Transplantation: A Randomized Open-Label Trial
OCA led to greater biochemical improvement, while better QoL was achieved with UDCA in LDLT recipients, with a comparable safety profile.
Authors
- Shweta Mallick (ORCID: https://orcid.org/0000-0001-5666-2239)
- Nafiya Muhammed Zackariah (ORCID: https://orcid.org/0000-0002-1378-6300)
- S Sudhindran (ORCID: https://orcid.org/0000-0002-9947-2678)
- Haritha Rajakrishnan
- Dinesh Balakrishnan
- G. Unnikrishnan
- S Saraswathy
- Anila KN
- Rajana Gopinath
- Sajitha Krishnan
Institutions
- Amrita Institute of Medical Sciences and Research Centre (IN)
Publication Details
- Journal
- Cureus
- Published
- 2025-11-27
- DOI
- https://doi.org/10.7759/cureus.97915
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00